ADB, Imexpharm Sign Agreement on Generic Medicine Production in Vietnam

The Asian Development Bank (ADB) signed an US$8 million loan with Imexpharm Corporation to help the company sustain its production of generic medicines despite global supply disruptions caused by the COVID-19 pandemic.

The financing will support the company’s working capital needs to ensure ample supply of active pharmaceutical ingredients for essential generic medicine production. Imexpharm’s operations and continued production of generic pharmaceuticals and their ensured availability in the market is integral in safeguarding the country’s health during the pandemic.

This debt financing is part of ADB’s US$20 billion assistance announced on April 13 to help its developing members manage the pandemic.

By L.A, Vietnam Business Forum